PLAKOUS THERAPEUTICS, INC.
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.1Mattributed |
|---|---|
| Latest round | grant, $2.1M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | WINSTON SALEM, North Carolina |
| Industry | bio |
| Stage | unknown |
| Website | plakoustherapeutics.com |
Plakous Therapeutics develops human-placental-extract biotherapeutics with anti-inflammatory and cell-proliferation activity. Lead programmes target paediatric necrotising enterocolitis and infant malabsorption with rare-paediatric and orphan-drug designations. The platform repositions birth-tissue extracts as a regenerative-medicine class.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $2.1M | undisclosed |
Detected tech stack
Nginx, WordPress, Typekit, Adobe Fonts, AitThemes, MonsterInsights 10.1.3, Yoast SEO 27.5, reCAPTCHA, Google Analytics, Google Tag Manager, Gravity Forms 2.10.1, jQuery Migrate 3.4.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.1M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.1M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | plakoustherapeutics.com, read 2026-05-08 |
| Description | self-reported | plakoustherapeutics.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.